Abstract
FIELD: biotechnology.
SUBSTANCE: Lactobacillus gasseri strain of BK-
2918D VKM having antagonistic activity against
Escherichia coli strains and a composition containing
the strain of Lactobacillus gasseri ECM B-2918D and
lactoferrin have been claimed. Probiotic strain
lactobacillus gasseri and its composition with lactoferrin
for prevention of diarrhea, nerrocessing enterherolite and sepsis caused by escherichia coli strains in prematurely born children.
EFFECT: expansion of the assortment of probiotic
drugs and nutrient mixtures that provide the formation
of normal microflora of the gastrointestinal tract in
prematurely born children.
| Original language | English |
|---|---|
| Publication status | Published - 16 Jan 2018 |
Bibliographical note
C12N 1/20 (2006.01); A61K 35/744 (2006.01); C12R 1/225 (2006.01)Patent applicant: not given
Keywords
- Agriculture, veterinary and food science
- Allied health professions and studies
- Biological sciences
- Infection and immunology
Fingerprint
Dive into the research topics of 'Probiotic strain 'Lactobacillus gasseri' and its composition with lactoferrin for prevention of diarrhea, nerrocessing enterherolite and sepsis caused by 'Escherichia coli' strains in prematurely born children'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver